BCM
GOSS icon

Bridgeway Capital Management’s Gossamer Bio GOSS Stock Holding History

Bridgeway Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$5.26K – 1269
2026
Q1 		$5.26K Sell
200
-2,000
-91% -$251K ﹤0.01% 1220
2025
Q4 		$546K Sell
2,200
-1,999
-48% -$456K 0.01% 806
2025
Q3 		$883K Sell
4,199
-1,875
-31% -$331K 0.02% 717
2025
Q2 		$598K Sell
6,074
-937
-13% -$81.8K 0.01% 742
2025
Q1 		$617K Buy
7,011
+248
+4% +$22.9K 0.02% 709
2024
Q4 		$489K Sell
6,763
-137
-2% -$9.39K 0.01% 823
2024
Q3 		$544K Hold
6,900
– – 0.01% 843
2024
Q2 		$497K Buy
6,900
+6,687
+3,139% +$400K 0.01% 862
2024
Q1 		$20.1K Hold
213
– – ﹤0.01% 1291
2023
Q4 		$15.5K Hold
213
– – ﹤0.01% 1344
2023
Q3 		$14.2K Hold
213
– – ﹤0.01% 1350
2023
Q2 		$20.4K Sell
213
-2,236
-91% -$223K ﹤0.01% 1363
2023
Q1 		$247K Buy
+2,449
New +$375K 0.01% 1064

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Bridgeway Capital Management's GOSS Position: Q2 2026 in Review

Bridgeway Capital Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 200 shares — an estimated $5.26K sold.

Bridgeway Capital Management first reported a position in GOSS in Q1 2023 and held it in 13 quarters. The position peaked at $883K in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Bridgeway Capital Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 200 Gossamer Bio shares in Q2 2026, an estimated $5.26K.
  • Bridgeway Capital Management first reported a position in Gossamer Bio in Q1 2023 and held it in 13 quarters.
  • Bridgeway Capital Management's Gossamer Bio position peaked at $883K in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.